Form 4: Olema Pharma COO/CFO Gifts 225K Shares to Family Trust

Olema Pharmaceuticals' Chief Operating and Financial Officer, Shane Kovacs, gifted 225,000 shares of common stock to a family trust.

Summary

• Shane Kovacs, Chief Operating & Financial Officer of Olema Pharmaceuticals, Inc. (OLMA), reported a change in beneficial ownership.
• On November 26, 2025, Kovacs transferred 225,000 shares of Olema Pharmaceuticals Common Stock.
• The transfer was a bona fide gift to the Kovacs 2025 Family Trust, with no consideration received.
• Following this transaction, Kovacs directly owns 318,549 shares of Common Stock.
• Kovacs explicitly stated he does not retain voting, dispositive, or pecuniary interest over the shares held by the trust.

Sentiment

Score: 5

Explanation: Neutral. This Form 4 reports a personal financial transaction (a gift of shares) by an officer, which is a routine disclosure and does not inherently reflect positively or negatively on the company's operational or financial performance.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Transfer of 225,000 shares of common stock to the Kovacs 2025 Family Trust as a bona fide gift for no consideration.

Stakeholder Impact

• Shareholders: The transaction represents a reduction in direct beneficial ownership by a key executive, though the shares remain within a family trust. The executive explicitly disclaims voting, dispositive, or pecuniary interest over the gifted shares, which could be interpreted as a full divestment of control over those specific shares by the executive.

Key Dates

Keywords

Olema Pharmaceuticals, OLMA, Shane Kovacs, Form 4, Insider Transaction, Gift, Beneficial Ownership, Common Stock, Officer, COO, CFO